In this section you can log in on the Clearinghouse and submit your HIV/AIDS good practice materials. You can also edit or delete your previous uploads.

2019 EU Drug Markets Report from the EMCDDA and Europol

by European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and European Union Agency for Law Enforcement Cooperation (Europol)

This report provides a strategic and action-oriented analysis of the information available on Europe’s drug market. It uses a broad definition of the illicit drug market, encompassing the illicit production, trafficking, wholesale distribution and sale of controlled substances to the end user. The drug market has wide-ranging impacts on both security and public health, and therefore such a holistic and systemic perspective is important for the effective delivery and monitoring of drug control policy.

  • WHO European region
  • Care and support
  • Co-infections
  • Harm reduction
  • Human rights
  • Inequalities in health
  • Laws and regulations
  • Legislation
  • Migration
  • Monitoring and Evaluation
  • Policy
  • Stigma and discrimination
  • Treatment
  • Health care professionals
  • NGOs
  • People living with HIV (PLHIV)
  • People who use drugs (PUD)
  • Policy makers

Tweeter news